{
    "clinical_study": {
        "@rank": "25286", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Compare the bioavailability of polymer-coated and buffered ursodiol\n      (ursodeoxycholic acid) to unmodified ursodiol in patients with cystic fibrosis-associated\n      liver disease or chronic cholestatic liver disease.\n\n      II.  Compare the differences in pruritus, weight gain, and liver function for both\n      treatments."
        }, 
        "brief_title": "Phase II Pilot Study to Compare the Bioavailability of Buffered, Enteric-Coated Ursodiol With Unmodified Ursodiol for Chronic Cholestatic Liver Disease and Cystic Fibrosis-Associated Liver Disease", 
        "condition": [
            "Cystic Fibrosis", 
            "Gastrointestinal Diseases", 
            "Cholestasis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cholestasis", 
                "Cystic Fibrosis", 
                "Fibrosis", 
                "Gastrointestinal Diseases", 
                "Digestive System Diseases", 
                "Liver Diseases"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients are sequentially treated with 2 formulations of ursodeoxycholic acid:  unmodified\n      ursodiol (Actigall) and buffered, enteric-coated ursodiol (Ursocarb).  There is a 24-hour\n      washout between each 4-week course of therapy."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics--\n\n        Chronic cholestatic liver disease\n\n        Cystic fibrosis-associated liver disease\n\n        --Prior/Concurrent Therapy--\n\n        Usual and customary diet maintained throughout study, e.g., medium-chain triglyceride oil\n\n        --Patient Characteristics--\n\n        Pulmonary: No serious respiratory deficiency\n\n        No acute illness\n\n        No inability to swallow\n\n        No fertile women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "4 Months"
        }, 
        "enrollment": "20", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004315", 
            "org_study_id": "199/11827", 
            "secondary_id": "UCMC-CHMC-915717"
        }, 
        "intervention": {
            "intervention_name": "ursodiol", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Ursodeoxycholic Acid"
        }, 
        "keyword": [
            "cardiovascular and respiratory diseases", 
            "cholestasis", 
            "cystic fibrosis", 
            "gastrointestinal disorders", 
            "genetic diseases and dysmorphic syndromes", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Cincinnati", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "45229-3039"
                }, 
                "name": "Children's Hospital Medical Center - Cincinnati"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "Children's Hospital Medical Center, Cincinnati", 
            "last_name": "William Balistreri", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004315"
        }, 
        "source": "National Center for Research Resources (NCRR)", 
        "sponsors": {
            "collaborator": {
                "agency": "Children's Hospital Medical Center, Cincinnati", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "November 1995", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2002"
    }, 
    "geocoordinates": {
        "Children's Hospital Medical Center - Cincinnati": "39.103 -84.512"
    }
}